Zoetis Inc (NYSE:ZTS) – Investment analysts at Jefferies Group reduced their FY2017 earnings per share (EPS) estimates for shares of Zoetis in a note issued to investors on Tuesday. Jefferies Group analyst J. Holford now expects that the company will post earnings of $2.38 per share for the year, down from their previous forecast of $2.39. Jefferies Group has a “Buy” rating and a $89.00 price target on the stock. Jefferies Group also issued estimates for Zoetis’ FY2019 earnings at $3.59 EPS, FY2020 earnings at $4.06 EPS and FY2021 earnings at $4.47 EPS.

Zoetis (NYSE:ZTS) last posted its earnings results on Thursday, November 2nd. The company reported $0.65 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.63 by $0.02. The company had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.32 billion. Zoetis had a net margin of 18.29% and a return on equity of 62.39%. The business’s revenue for the quarter was up 8.5% compared to the same quarter last year. During the same period last year, the business posted $0.52 earnings per share.

Several other equities research analysts also recently issued reports on the stock. BMO Capital Markets set a $65.00 price objective on shares of Zoetis and gave the stock a “hold” rating in a research report on Wednesday, October 25th. Zacks Investment Research downgraded shares of Zoetis from a “hold” rating to a “sell” rating and set a $83.00 price objective for the company. in a research report on Saturday, January 13th. Cantor Fitzgerald reissued a “buy” rating and set a $75.00 price objective on shares of Zoetis in a research report on Tuesday, October 24th. BidaskClub downgraded shares of Zoetis from a “hold” rating to a “sell” rating in a research report on Friday, October 6th. Finally, Cowen set a $80.00 price objective on shares of Zoetis and gave the stock a “buy” rating in a research report on Friday, November 17th. Two equities research analysts have rated the stock with a sell rating, four have given a hold rating and fourteen have issued a buy rating to the company’s stock. Zoetis currently has an average rating of “Buy” and an average target price of $73.00.

Shares of Zoetis (NYSE ZTS) opened at $76.77 on Thursday. The company has a quick ratio of 1.95, a current ratio of 2.80 and a debt-to-equity ratio of 2.45. The firm has a market cap of $37,410.00, a price-to-earnings ratio of 40.41, a price-to-earnings-growth ratio of 1.90 and a beta of 1.06. Zoetis has a twelve month low of $52.00 and a twelve month high of $77.03.

A number of institutional investors have recently added to or reduced their stakes in ZTS. Janus Henderson Group PLC grew its position in Zoetis by 7,717.4% in the second quarter. Janus Henderson Group PLC now owns 5,809,086 shares of the company’s stock valued at $362,372,000 after purchasing an additional 5,734,776 shares in the last quarter. Vanguard Group Inc. grew its position in Zoetis by 2.8% in the second quarter. Vanguard Group Inc. now owns 33,654,686 shares of the company’s stock valued at $2,099,379,000 after purchasing an additional 910,265 shares in the last quarter. Parametric Portfolio Associates LLC grew its position in Zoetis by 68.1% in the second quarter. Parametric Portfolio Associates LLC now owns 1,683,496 shares of the company’s stock valued at $105,016,000 after purchasing an additional 681,877 shares in the last quarter. Renaissance Technologies LLC grew its position in Zoetis by 51.2% in the second quarter. Renaissance Technologies LLC now owns 1,711,100 shares of the company’s stock valued at $106,738,000 after purchasing an additional 579,400 shares in the last quarter. Finally, Milestone Resources Group Ltd bought a new position in Zoetis in the fourth quarter valued at $40,294,000. 93.14% of the stock is owned by institutional investors and hedge funds.

The firm also recently announced a quarterly dividend, which will be paid on Thursday, March 1st. Investors of record on Friday, January 19th will be given a $0.126 dividend. The ex-dividend date is Thursday, January 18th. This represents a $0.50 dividend on an annualized basis and a yield of 0.66%. This is an increase from Zoetis’s previous quarterly dividend of $0.11. Zoetis’s dividend payout ratio (DPR) is 22.11%.

TRADEMARK VIOLATION WARNING: This piece was first reported by American Banking News and is owned by of American Banking News. If you are reading this piece on another site, it was illegally copied and reposted in violation of international copyright & trademark legislation. The correct version of this piece can be viewed at https://www.americanbankingnews.com/2018/01/18/jefferies-group-analysts-decrease-earnings-estimates-for-zoetis-inc-zts.html.

About Zoetis

Zoetis Inc is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a business, commercializing products across eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock) and dogs, cats and horses (collectively, companion animals), and within five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals.

Earnings History and Estimates for Zoetis (NYSE:ZTS)

Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.